🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide 50mg (Rybelsus HD) — 12 month update Page 3

Oral semaglutide 50mg (Rybelsus HD) — 12 month update

LibrarianMeg Thu, May 30, 2024 at 6:09 AM 44 replies 2,300 viewsPage 3 of 9
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
May 31, 2024 at 10:02 AM#11
Dr.DermMIA said:
Steady state is the thing most people miss.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Last edited: May 31, 2024 at 12:02 PM
9 9JakeSmashed95, NauseaFreeNow, SteveThurs and 6 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Jun 1, 2024 at 4:55 AM#12
Dr.MetabolicMD said:
The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest.

This answered a question I did not know how to ask.

8 8Dr.ObesityLA, NurseKim_ATL, paul_denver and 5 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Jun 1, 2024 at 11:48 PM#13
Dr.DermMIA said:
Steady state is the thing most people miss.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

7 7kevin_tulsa, Dr.PainCLE, mike_mealprep and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Jun 2, 2024 at 6:42 PM#14

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Last edited: Jun 2, 2024 at 7:42 PM
6 6PharmHunterJen, TomTeleRx, DoseLogDan and 3 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 3, 2024 at 1:36 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out.

5 5PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 2 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register